Seegene in the coming week will unveil a new technology that enables highly multiplexed melt curve analysis on existing commercial real-time PCR instruments.
The FDA recently awarded 510(k) clearance to Idaho Technology's FilmArray Respiratory Panel, but the company has chosen not to commercialize the product, instead awaiting FDA clearance for a follow-on version containing two additional targets.
Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.
The New York Times reports on the shifting interpretations of what some genetic variants mean over time.
In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.
MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.